The Vantage Team
As operators, investors and government officials, with 60+ years of experience, $2bn AUM and 200+ portfolio companies, we had to find another way to level the playing field for our key assets and partners maximizing their opportunity to bring novel innovations to market.
Our Commitment to Excellence
Expertise
World-class professionals with deep expertise in clinical research
Global Perspective
International experience across multiple markets and regulatory environments
Collaboration
Working closely with clients to achieve their drug development goals
Leadership Team
Our leadership team brings together decades of experience in clinical research, regulatory affairs, and healthcare innovation to drive excellence in everything we do.
Photo Coming Soon
Dr. Aida Kenzhebekova
Chief Executive Officer
Leading clinical research expert with 15+ years of experience in international pharmaceutical development. Dr. Kenzhebekova has successfully led over 200 clinical trials and has been instrumental in bringing numerous life-saving treatments to market.
Key Achievements
- Led 200+ clinical trials
- Published 50+ research papers
- International recognition for excellence
Specialties
Photo Coming Soon
Dr. Murat Tulegenov
Chief Medical Officer
Renowned cardiologist and clinical investigator with extensive experience in cardiovascular trials. Dr. Tulegenov has been at the forefront of innovative cardiac treatments and has contributed significantly to advancing cardiovascular medicine.
Key Achievements
- Pioneered new cardiac procedures
- International speaker and educator
- Award-winning researcher
Specialties
Our Expert Team
Our diverse team of professionals brings together decades of experience in clinical research, regulatory affairs, and healthcare innovation.
Advisory Board
Our advisory board consists of world-renowned experts in regulatory affairs, biostatistics, and clinical research who guide our strategic direction and ensure the highest standards of excellence.
Photo Coming Soon
Dr. Sarah Johnson
Head of Regulatory Affairs
Former FDA Senior Reviewer
International regulatory expert specializing in FDA and EMA submissions for pharmaceutical products. Dr. Johnson brings over 10 years of regulatory experience from the FDA.
Areas of Expertise
Key Achievements
- Former FDA Senior Reviewer
- Led 50+ successful drug approvals
- International regulatory consultant
Photo Coming Soon
Prof. Michael Chen
Chief Scientific Officer
Harvard Medical School
Distinguished researcher and biostatistician with expertise in clinical trial design and data analysis. Prof. Chen has published over 100 peer-reviewed papers.
Areas of Expertise
Key Achievements
- 100+ peer-reviewed publications
- International research collaborations
- Award-winning statistician
Why Our Advisory Board Matters
Global Perspective
International expertise from leading institutions worldwide
Proven Track Record
Decades of successful clinical research and regulatory experience
Continuous Learning
Stay ahead with cutting-edge research and industry best practices